Altano Capital
altano-capital.com Direct investor
Altano Capital is a healthcare and med-tech investor that makes buy-out investments and minority early-stage investments, with a focus on supporting expansion into the U.S. and China. Its portfolio includes cardio-vascular device and sales companies in Germany and England.
Altano Capital is a private equity firm. It invests directly in companies, at buyout, in life-science, healthcare, medical devices and med-tech. 5 portfolio companies, as it reports.
“Our goal is to find promising life-science companies and talented entrepreneurs with the potential to change the healthcare industry.”
— Altano Capital, own website
- Layer
- Direct investor
- Type
- Private equity
- Stage
- Buyout
- Invests in
- Europe, China, U.S.
- Sectors
- life-science, healthcare, medical devices, med-tech
- Portfolio
- 5 companies
Team, as Altano Capital publishes it
- Daniel Mahnert-Lueg Partner
Names and roles exactly as listed on altano-capital.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Altano Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.altano-capital.com/name, is_investor, layer, type, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, description, status, confidence
- https://www.altano-capital.com/portfolioportfolio_count
- https://www.altano-capital.com/teampeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 17553 · added 2026-10-26 · link last verified 2026-10-26 · confidence medium
Similar investors
- Bluestem Capital Company, LLCPrivate equity · Growth – Buyout · Sioux Falls, United States
- Evolve Healthcare PartnersPrivate equity · Buyout
- LYFE CapitalPrivate equity · Growth – Buyout
- Mérieux Equity PartnersPrivate equity · Seed – Buyout · Paris, France
- MVM Partners LLPPrivate equity · Growth · London, United Kingdom
- Serendipity PartnersPrivate equity · Growth – Buyout · Norway